UNSPSC 51334002: Spiramide

This classification denotes an antipsychotic agent with the molecular formula C22H26FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 471LF4O004, chemically known as 1,3,8-triazaspiro(4.5)decan-4-one, 8-(3-(4-fluorophenoxy)propyl)-1-phenyl- but generally known as spiramide, which bears US NIH Compound Identifier 68186. European Medicines Agency schedules Spiramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10619MIG.

UNSPSC 51334002 Spiramide is a Commodity code that captures pharmaceutical procurement by state and local health agencies, though the recent solicitation activity under this code reflects a broader public health mission centered on opioid-crisis response and harm reduction. State and local governments are buying naloxone (an opioid antagonist) and drug deactivation systems through this code, supporting community health departments and emergency response initiatives. The issuing bodies include county health departments and public health authorities pursuing competitive bidding for routine pharmaceutical and medical supply replenishment.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through its e-Procurement Portal, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid deadline was July 26, 2023, and vendors were required to include all shipping and delivery costs in their proposals. The contract included a two-year initial term with a one-year renewal option and carried potential FEMA funding with associated federal compliance requirements. This represents the primary recent activity visible under the code; geographic concentration in the recent opportunities block is limited to Florida, and issuing-body diversity is narrow. Bidders needed E-Verify certification, drug-free workplace compliance, and specified insurance coverage, with contract award on a fixed-fee basis and a three-month probationary termination clause.